• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血尿有多良性?利用遗传学预测预后。

How benign is hematuria? Using genetics to predict prognosis.

机构信息

University College London-Centre for Nephrology, Royal Free Hospital Pond Street, London, NW3 2QG, UK.

出版信息

Pediatr Nephrol. 2013 Aug;28(8):1183-93. doi: 10.1007/s00467-012-2399-y. Epub 2013 Jan 17.

DOI:10.1007/s00467-012-2399-y
PMID:23325022
Abstract

Hematuria is a common presenting feature of glomerular disease and is sometimes associated with kidney failure later in life. Where isolated microscopic hematuria occurs in children and young adults, an underlying monogenic disorder, such as Alport syndrome or thin basement membrane nephropathy, is frequently responsible. In this review, these and other diseases, which often present with isolated microscopic hematuria, including hereditary angiopathy, nephropathy, aneurysms, and muscle cramps (HANAC) syndrome, IgA nephropathy, and CFHR5 nephropathy, are discussed together with the associated molecular pathology, clinical features, and prognosis. Genetic testing for these conditions used in clinical practice can provide important diagnostic and prognostic information that is relevant to the patient and their family, particularly when kidney transplantation is considered.

摘要

血尿是肾小球疾病的常见表现,有时与日后的肾衰竭有关。在儿童和青年中出现孤立性镜下血尿时,常与 Alport 综合征或薄基底膜肾病等单基因疾病有关。在本综述中,我们将讨论这些疾病以及其他常表现为孤立性镜下血尿的疾病,包括遗传性血管病、肾病、动脉瘤和肌肉痉挛(HANAC)综合征、IgA 肾病和 CFHR5 肾病,以及相关的分子病理学、临床特征和预后。这些疾病的临床实践中使用的基因检测可以提供重要的诊断和预后信息,与患者及其家属密切相关,特别是在考虑肾移植时。

相似文献

1
How benign is hematuria? Using genetics to predict prognosis.血尿有多良性?利用遗传学预测预后。
Pediatr Nephrol. 2013 Aug;28(8):1183-93. doi: 10.1007/s00467-012-2399-y. Epub 2013 Jan 17.
2
Hematuria and risk for end-stage kidney disease.血尿与终末期肾病风险。
Curr Opin Nephrol Hypertens. 2013 May;22(3):325-30. doi: 10.1097/MNH.0b013e32835f7241.
3
Familial hematuria: A review.家族性血尿:综述
Medicina (Kaunas). 2017;53(1):1-10. doi: 10.1016/j.medici.2017.01.002. Epub 2017 Jan 31.
4
COL4A1 mutations and hereditary angiopathy, nephropathy, aneurysms, and muscle cramps.COL4A1基因变异与遗传性血管病、肾病、动脉瘤和肌肉痉挛。
N Engl J Med. 2007 Dec 27;357(26):2687-95. doi: 10.1056/NEJMoa071906.
5
Thin GBM nephropathy: premature glomerular obsolescence is associated with hypertension and late onset renal failure.薄基底膜肾病:肾小球过早荒废与高血压及迟发性肾衰竭相关。
Kidney Int. 1997 May;51(5):1596-601. doi: 10.1038/ki.1997.219.
6
Expert guidelines for the management of Alport syndrome and thin basement membrane nephropathy.《Alport 综合征及薄基底膜肾病管理专家指南》
J Am Soc Nephrol. 2013 Feb;24(3):364-75. doi: 10.1681/ASN.2012020148. Epub 2013 Jan 24.
7
[Collagen type IV nephropathy: from thin basement membrane nephropathy to Alport syndrome].[IV型胶原肾病:从薄基底膜肾病到Alport综合征]
Orv Hetil. 2005 Dec 25;146(52):2647-53.
8
Frequent COL4 mutations in familial microhematuria accompanied by later-onset Alport nephropathy due to focal segmental glomerulosclerosis.常染色体显性遗传家族性镜下血尿伴局灶节段性肾小球硬化所致晚发型 Alport 肾病中 COL4 基因突变频繁发生。
Clin Genet. 2017 Nov;92(5):517-527. doi: 10.1111/cge.13077. Epub 2017 Sep 25.
9
[Genetic variants of familial hematuria associated genes in three families with hematuria with probands initially diagnosed as IgA nephropathy].[三个血尿家系中先证者初诊为IgA肾病的家族性血尿相关基因的遗传变异]
Zhonghua Er Ke Za Zhi. 2019 Sep 2;57(9):674-679. doi: 10.3760/cma.j.issn.0578-1310.2019.09.006.
10
Renal diseases associated with hematuria in children and adolescents: a brief tutorial.儿童和青少年与血尿相关的肾脏疾病:简要教程
Ultrastruct Pathol. 2012 Feb;36(1):1-18. doi: 10.3109/01913123.2011.620731.

引用本文的文献

1
Novel synonymous mutation causes Alport syndrome coexistent with immunoglobulin A nephropathy in a woman: A case report.新型同义突变导致一名女性患阿尔波特综合征并伴有免疫球蛋白A肾病:病例报告
World J Clin Cases. 2023 Sep 6;11(25):5947-5953. doi: 10.12998/wjcc.v11.i25.5947.
2
Identification of variants in Chinese patients with familial hematuria.中国家族性血尿患者变异的鉴定。
Front Genet. 2023 Jan 9;13:1064491. doi: 10.3389/fgene.2022.1064491. eCollection 2022.
3
Raising the Volume on Alport Syndrome: A Patient Perspective.

本文引用的文献

1
Long-term outcomes of IgA nephropathy presenting with minimal or no proteinuria.表现为少量蛋白尿或无蛋白尿的 IgA 肾病的长期预后。
J Am Soc Nephrol. 2012 Oct;23(10):1753-60. doi: 10.1681/ASN.2012010063. Epub 2012 Sep 6.
2
Safety and Efficacy of the ACE-Inhibitor Ramipril in Alport Syndrome: The Double-Blind, Randomized, Placebo-Controlled, Multicenter Phase III EARLY PRO-TECT Alport Trial in Pediatric Patients.血管紧张素转换酶抑制剂雷米普利在奥尔波特综合征中的安全性和有效性:针对儿科患者的双盲、随机、安慰剂对照、多中心III期EARLY PRO-TECT奥尔波特试验
ISRN Pediatr. 2012;2012:436046. doi: 10.5402/2012/436046. Epub 2012 Jul 1.
3
提高对奥尔波特综合征的关注度:患者视角
Kidney360. 2020 Mar 12;1(4):227-228. doi: 10.34067/KID.0000692020. eCollection 2020 Apr 30.
4
Tale of two nephropathies; co-occurring Alport syndrome and IgA nephropathy, a case report.两种肾病;同时发生的 Alport 综合征和 IgA 肾病,病例报告。
BMC Nephrol. 2021 Oct 30;22(1):358. doi: 10.1186/s12882-021-02567-9.
5
Co-existence of Alport syndrome and C3 glomerulonephritis in a proband with family history.先证者有家族史,同时存在 Alport 综合征和 C3 肾小球肾炎。
Eur J Med Res. 2021 Jul 8;26(1):71. doi: 10.1186/s40001-021-00543-5.
6
Genetic mutational testing of Chinese children with familial hematuria with biopsy‑proven FSGS.对经活检证实为 FSGS 的有家族性血尿的中国儿童进行遗传突变检测。
Mol Med Rep. 2018 Jan;17(1):1513-1526. doi: 10.3892/mmr.2017.8023. Epub 2017 Nov 10.
7
Prevalence of hypertension, obesity, hematuria and proteinuria amongst healthy adolescents living in Western Saudi Arabia.沙特阿拉伯西部健康青少年中高血压、肥胖、血尿和蛋白尿的患病率。
Saudi Med J. 2016 Oct;37(10):1120-6. doi: 10.15537/smj.2016.10.14784.
8
A novel COL4A1 frameshift mutation in familial kidney disease: the importance of the C-terminal NC1 domain of type IV collagen.家族性肾病中的一种新型COL4A1移码突变:IV型胶原C端NC1结构域的重要性。
Nephrol Dial Transplant. 2016 Nov;31(11):1908-1914. doi: 10.1093/ndt/gfw051. Epub 2016 Apr 8.
9
Isolated microscopic haematuria of glomerular origin: clinical significance and diagnosis in the 21st century.孤立性肾小球源性镜下血尿:21世纪的临床意义与诊断
Clin Med (Lond). 2015 Dec;15(6):576-80. doi: 10.7861/clinmedicine.15-6-576.
10
Haematuria increases progression of advanced proteinuric kidney disease.血尿会加速晚期蛋白尿性肾病的进展。
PLoS One. 2015 May 27;10(5):e0128575. doi: 10.1371/journal.pone.0128575. eCollection 2015.
COL4A1 mutations in patients with sporadic late-onset intracerebral hemorrhage.
COL4A1 突变与散发性晚发性脑出血患者。
Ann Neurol. 2012 Apr;71(4):470-7. doi: 10.1002/ana.22682.
4
Clinical practice recommendations for the treatment of Alport syndrome: a statement of the Alport Syndrome Research Collaborative.临床实践中治疗 Alport 综合征的建议:Alport 综合征研究协作组的声明。
Pediatr Nephrol. 2013 Jan;28(1):5-11. doi: 10.1007/s00467-012-2138-4. Epub 2012 Mar 30.
5
The role of kidney biopsy to determine donation from prospective kidney donors with asymptomatic urinary abnormalities.肾活检在确定无症状性泌尿系统异常的潜在肾供体是否适合捐献中的作用。
Transplant Proc. 2012 Jan;44(1):11-3. doi: 10.1016/j.transproceed.2011.12.008.
6
Incidence of renal failure and nephroprotection by RAAS inhibition in heterozygous carriers of X-chromosomal and autosomal recessive Alport mutations.X 连锁和常染色体隐性 Alport 突变杂合子携带者中 RAAS 抑制的肾衰竭发生率和肾脏保护作用。
Kidney Int. 2012 Apr;81(8):779-83. doi: 10.1038/ki.2011.452. Epub 2012 Jan 11.
7
Folding delay and structural perturbations caused by type IV collagen natural interruptions and nearby Gly missense mutations.IV 型胶原天然中断和附近 Gly 错义突变引起的折叠延迟和结构扰动。
J Biol Chem. 2012 Feb 3;287(6):4368-75. doi: 10.1074/jbc.M111.269084. Epub 2011 Dec 16.
8
Early angiotensin-converting enzyme inhibition in Alport syndrome delays renal failure and improves life expectancy.早期血管紧张素转换酶抑制剂治疗 Alport 综合征可延缓肾衰竭并提高预期寿命。
Kidney Int. 2012 Mar;81(5):494-501. doi: 10.1038/ki.2011.407. Epub 2011 Dec 14.
9
Persistent asymptomatic isolated microscopic hematuria in Israeli adolescents and young adults and risk for end-stage renal disease.以色列青少年和年轻成年人持续无症状孤立性镜下血尿与终末期肾病风险。
JAMA. 2011 Aug 17;306(7):729-36. doi: 10.1001/jama.2011.1141.
10
The role of molecular genetics in diagnosing familial hematuria(s).分子遗传学在家族性血尿诊断中的作用。
Pediatr Nephrol. 2012 Aug;27(8):1221-31. doi: 10.1007/s00467-011-1935-5. Epub 2011 Jun 19.